Guido, Maria Carolina 
; Lopes, Natalia de Menezes ; Albuquerque, Camila Inagaki ; Tavares, Elaine Rufo ; Jensen, Leonardo; Carvalho, Priscila de Oliveira; Tavoni, Thauany Martins ; Dias, Ricardo Ribeiro; Pereira, Lygia da Veiga ; Laurindo, Francisco Rafael Martins; Maranhão, Raul Cavalcante
Source: Frontiers in Cardiovascular Medicine. Unidades: FM, FCF
Subjects: ADENOSINA, NANOPARTÍCULAS, INFLAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIDO, Maria Carolina et al. Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome. Frontiers in Cardiovascular Medicine, v. 9, p. 1-13 art. 893774, 2022Tradução . . Disponível em: https://doi.org/10.3389/fcvm.2022.893774. Acesso em: 19 nov. 2024.APA
Guido, M. C., Lopes, N. de M., Albuquerque, C. I., Tavares, E. R., Jensen, L., Carvalho, P. de O., et al. (2022). Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome. Frontiers in Cardiovascular Medicine, 9, 1-13 art. 893774. doi:10.3389/fcvm.2022.893774NLM
Guido MC, Lopes N de M, Albuquerque CI, Tavares ER, Jensen L, Carvalho P de O, Tavoni TM, Dias RR, Pereira L da V, Laurindo FRM, Maranhão RC. Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome [Internet]. Frontiers in Cardiovascular Medicine. 2022 ; 9 1-13 art. 893774.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fcvm.2022.893774Vancouver
Guido MC, Lopes N de M, Albuquerque CI, Tavares ER, Jensen L, Carvalho P de O, Tavoni TM, Dias RR, Pereira L da V, Laurindo FRM, Maranhão RC. Treatment with methotrexate associated with lipid core nanoparticles prevents aortic dilation in a murine model of Marfan syndrome [Internet]. Frontiers in Cardiovascular Medicine. 2022 ; 9 1-13 art. 893774.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fcvm.2022.893774
